Chromosome translocations in workers exposed to benzene

Journal of the National Cancer Institute - Monographs

Volumn , Issue 39, 2008, Pages 74-77

  Mchale, Cliona M ^a   Lan, Qing ^b   Corso, Chiara ^a   Li, Guilan ^c   Zhang, Luoping ^a   Vermeulen, Roel ^d   Curry, John D ^a   Shen, Min ^b   Turakulov, Rustam ^d   Higuchi, Russell ^e   Germer, Soren ^a   Yin, Songnian ^c   Rothman, Nathaniel ^b   Smith, Martyn T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d UTRECHT UNIVERSITY   (Netherlands)

^e ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; BREAKPOINT CLUSTER REGION PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 2; TUMOR MARKER;

ADULT; B LYMPHOCYTE; CANCER INCIDENCE; CANCER RISK; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOTOXICITY; LEUKEMIA; MALE; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE SEQUENCE; OCCUPATIONAL EXPOSURE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; BENZENE; CARCINOGENS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN; FEMALE; GENES, BCL-2; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA; MALE; OCCUPATIONAL EXPOSURE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 52149109142     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgn010     Document Type: Conference Paper

References (35)

1. Hayes RB, Yin S, Rothman N, et al. Benzene and lymphohematopoietic malignancies in China. J Toxicol Environ Health A. 2000;61(5-6): 419-432.
2. Hayes RB, Yin SN, Dosemeci M, et al. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine - National Cancer Institute Benzene Study Group. J Natl Cancer Inst. 1997;89(14):1065-1071.
3. Zhang L, Eastmond DA, Smith MT. The nature of chromosomal aberrations detected in humans exposed to benzene. Crit Rev Toxicol. 2002; 32(1):1-42.
4. Peterson LF, Zhang DE. The 8;21 translocation in leukemogenesis. Oncogene. 2004;23(24):4255-4262.
5. Sirulnik A, Melnick A, Zelent A, Licht JD. Molecular pathogenesis of acute promyelocytic leukaemia and APL variants. Best Pract Res Clin Haematol. 2003;16(3):387-408.
6. Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res. 1992;52(19):5432s-5440s.
7. Mori H, Colman SM, Xiao Z, et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA. 2002;99(12):8242-8247.
8. Quina AS, Gameiro P, Sa da Costa M, Telhada M, Parreira L. PMLRARA fusion transcripts in irradiated and normal hematopoietic cells. Genes Chromosomes Cancer. 2000;29(3):266-275.
9. Janz S, Potter M, Rabkin CS. Lymphoma-and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer. 2003;36(3):211-223.
10. Basecke J, Griesinger F, Trumper L, Brittinger G. Leukemia-and lymphoma-associated genetic aberrations in healthy individuals. Ann Hematol. 2002;81(2):64-75.
11. Fuscoe JC, Setzer RW, Collard DD, Moore MM. Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogens. Carcinogenesis. 1996; 17(5):1013-1020.
12. Limpens J, Stad R, Vos C, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood. 1995;85(9): 2528-2536.
13. Schmitt C, Balogh B, Grundt A, et al. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity. Leuk Res. 2006;30(6): 745-750.
14. Bell DA, Liu Y, Cortopassim GA. Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J Natl Cancer Inst. 1995;87(3):223-224.
15. Liu Y, Hernandez AM, Shibata D, Cortopassi GA. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA. 1994;91(19): 8910-8914.
16. O'Donovan MR, Johns S, Wilcox P. The effect of PHA stimulation on lymphocyte sub-populations in whole-blood cultures. Mutagenesis. 1995; 10(4):371-374.
17. Akasaka T, Akasaka H, Yonetani N, et al. Refinement of the BCL2/ immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets. Genes Chromosomes Cancer. 1998;21(1):17-29.
18. Albinger-Hegyi A, Hochreutener B, Abdou MT, et al. High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: Improved polymerase chain reaction protocols for their detection. Am J Pathol. 2002;160(3):823-832.
19. Smith MT, Zhang L, Wang Y, et al. Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res. 1998;58(10):2176-2181.
20. Zhang L, Rothman N, Li G, et al. Aberrations in chromosomes associated with lymphoma and therapy-related leukemia in benzene-exposed workers. Environ Mol Mutagen. 2007;48(6):467-474.
21. Vermeulen R, Li G, Lan Q, et al. Detailed exposure assessment for a molecular epidemiology study of benzene in two shoe factories in China. Ann Occup Hyg. 2004;48(2):105-116.
22. Lan Q, Zhang L, Li G, et al. Hematotoxicity in workers exposed to low levels of benzene. Science. 2004;306(5702):1774-1776.
23. Luthra R, McBride JA, Cabanillas F, Sarris A. Novel 5′ exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma. Am J Pathol. 1998;153(1):63-68.
24. Curry J, McHale C, Smith MT. Low efficiency of the Moloney murine leukemia virus reverse transcriptase during reverse transcription of rare t(8;21) fusion gene transcripts. Biotechniques. 2002;32(4):768, 70, 72, 54-5.
25. Marcucci G, Livak KJ, Bi W, Strout MP, Bloomfield CD, Caligiuri MA. Detection of minimal residual disease in patients with AML1/ ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay. Leukemia. 1998;12(9):1482-1489.
26. Sarris AH, Jiang Y, Tsimberidou AM, et al. Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone. Semin Oncol. 2002;29(1 suppl 2): 48-55.
27. Pallisgaard N, Clausen N, Schroder H, Hokland P. Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative realtime RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer. 1999;26(4):355-365.
28. Bogadi-Sare A, Zavalic M, Trosic I, Turk R, Kontosic I, Jelcic I. Study of some immunological parameters in workers occupationally exposed to benzene. Int Arch Occup Environ Health. 2000;73(6):397-400.
29. Dolken L, Schuler F, Dolken G. Frequency of BCL-2/J(H) translocation in healthy males exposed to low-level radiation in comparison to age-matched health controls. Blood. 2002;100(4):1513-1514.
30. Roulland S, Lebailly P, Lecluse Y, Heutte N, Nadel B, Gauduchon P. Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals. Leukemia. 2006;20(1):158-162.
31. Giannelli F, Moscarella S, Giannini C, et al. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood. 2003;102(4):1196-1201.
32. Baccarelli A, Hirt C, Pesatori AC, et al.(14;18) translocations in lymphocytes of healthy dioxin-exposed individuals from Seveso, Italy. Carcinogenesis. 2006;27(10):2001-2007.
33. Snyder R. Overview of the toxicology of benzene. J Toxicol Environ Health A. 2000;61(5-6):339-346.
34. Yasukawa M, Bando S, Dolken G, et al. Low frequency of BCL-2/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals. Blood. 2001;98(2):486-488.
35. Aplan PD. Causes of oncogenic chromosomal translocation. Trends Genet. 2006;22(1):46-55.